{{Rsnum
|rsid=3772219
|Gene=ARHGEF3
|Chromosome=3
|position=56737223
|Orientation=minus
|GMAF=0.4059
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=ARHGEF3
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 9.7 | 40.7 | 49.6
| HCB | 15.4 | 41.9 | 42.6
| JPT | 20.4 | 48.7 | 31.0
| YRI | 36.1 | 46.9 | 17.0
| ASW | 19.3 | 61.4 | 19.3
| CHB | 15.4 | 41.9 | 42.6
| CHD | 17.4 | 53.2 | 29.4
| GIH | 5.0 | 41.6 | 53.5
| LWK | 32.1 | 42.2 | 25.7
| MEX | 17.2 | 60.3 | 22.4
| MKK | 20.8 | 51.3 | 27.9
| TSI | 4.9 | 35.3 | 59.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs3772219
|Name_s=
|Gene_s=ARHGEF3
|Feature=
|Evidence=PubMed ID:18499081
|Annotation=In family-based association tests of women from Australia and the UK, rs3772219 was one of five SNPs that demonstrated significant association with decreased age-adjusted bone mineral density.
|Drugs=
|Drug Classes=
|Diseases=Osteoporosis
|Curation Level=Curated
|PharmGKB Accession ID=PA161748318
}}

{{GET Evidence
|gene=ARHGEF3
|aa_change=Leu367Val
|aa_change_short=L367V
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3772219
|overall_frequency_n=4138
|overall_frequency_d=10758
|overall_frequency=0.384644
|n_genomes=35
|n_genomes_annotated=0
|n_haplomes=46
|n_articles=0
|n_articles_annotated=0
|nblosum100=0
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}